CSIMarket Company Name, Ticker, Industry, else..


Pfizer Inc  (PFE)
Other Ticker:  
 

Pfizer Inc

PFE's Fundamental analysis



Pfizer Inc's sales fell by -54.1 % in II. Quarter 2023 from the same quarter a year ago. Ranking at No. 1389

Major Pharmaceutical Preparations industry recorded growth of revenues by 24.84 %

Pfizer Inc's net profit deacreased by -76.41 % in II. Quarter 2023 year on year, to $2,338 millions.

• More on PFE's Growth


Pfizer Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 213.93 in trailing twelve-month period.
Company
8.69
PE TTM   
Industry
0.02
PE TTM    
Company's Price to Sales ratio is at 2.4.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.82.


• More on PFE's Valuation
 
 Total Debt (Millions $) 65,341
 Dividend TTM ($) 1.59 $
 Dividend Yield TTM (%) 4.96 %
 Revenue/Employee (TTM) $ 986,620
 Net Income/Employee (TTM) $ 272,405
 Receivable Turnover (TTM) 6.29
 Tangible Book Value (Per Share $) 1.11

Pfizer Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 213.93 in trailing twelve-month period.
Company
8.69
PE TTM   
Industry
0.02
PE TTM    
Company's Price to Sales ratio is at 2.4.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.82.

Pfizer Inc Price to Book Ratio is at 1.88 lower than Indusry Avg. of 1178.55. and lower than S&P 500 Avg. of 1171.69

• More on PFE's Valuation

•  Market Capitalization (Millions $) 186,758
•  Shares Outstanding (Millions) 5,713
•  Employees 79,000
•  Revenues (TTM) (Millions $) 77,943
•  Net Income (TTM) (Millions $) 21,520
•  Cash Flow (TTM) (Millions $) 873
•  Capital Exp. (TTM) (Millions $) -3,895
•  Total Debt (Millions $) 65,341
•  Dividend TTM ($) 1.59 $
•  Dividend Yield TTM (%) 4.96 %
•  Revenue/Employee (TTM) $ 986,620
•  Net Income/Employee(TTM) $ 272,405
•  Receivable Turnover Ratio (TTM) 6.29
•  Tangible Book Value (Per Share $) 1.11

•  Market Capitalization (Millions $) 186,758
•  Shares Outstanding (Millions) 5,713
•  Employees 79,000
•  Revenues (TTM) (Millions $) 77,943
•  Net Income (TTM) (Millions $) 21,520
•  Cash Flow (TTM) (Millions $) 873
•  Capital Exp. (TTM) (Millions $) -3,895


    PFE's Profitability Comparisons
Pfizer Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in II. Quarter 2023 to 15.34 % from 34.79 % in I. Quarter.

Pfizer Inc net profit margin of 18.36 % is currently ranking no. 19 in Major Pharmaceutical Preparations industry, ranking no. 38 in Healthcare sector and number 569 in S&P 500.


Profitability by Segment



  Ratio
•   Capital Ratio (MRQ) 2.12
•  Total Debt to Equity (MRQ) 0.66
•  Tangible Leverage Ratio (MRQ) 19.18
•  Asset Turnover Ratio (TTM) 0.39
•  Inventory Turnover Ratio (TTM) 2.49



Pfizer Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in II. Quarter 2023 to 15.34 % from 34.79 % in I. Quarter.

Pfizer Inc net profit margin of 18.36 % is currently ranking no. 19 in Major Pharmaceutical Preparations industry, ranking no. 38 in Healthcare sector and number 569 in S&P 500.

• More on PFE's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com